Sana Biotechnology, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Sana Biotechnology, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026, with key proposals including director elections and auditor ratification.
NASDAQ
Sana Biotechnology will hold its annual meeting of stockholders virtually on June 5, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Sana Biotechnology announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, featuring director elections and ratification of the independent accounting firm.
NASDAQ
Sana Biotechnology will hold its annual stockholders meeting virtually on June 6, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Sana Biotechnology will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, to elect directors and ratify the appointment of its independent accounting firm.